GNH USA

Europe — EMA

Imovax D.T. Adult

GNH USA supplies Imovax D.T. Adult (Diphtheria and tetanus toxoids), a vaccine for prevention of diphtheria and tetanus.

Diphtheria Toxoid, Tetanus Toxoid, Algeldrate

Request sourcing

1
Pack/s

What is Diphtheria Toxoid, Tetanus Toxoid, Algeldrate?

Diphtheria and tetanus toxoids vaccine, the active ingredient in Imovax D.T. Adult, is a vaccine presented as an injectable solution for intramuscular or subcutaneous use. It provides active immunization against diphtheria and tetanus in adults and adolescents.

GNH USA supplies Imovax D.T. Adult as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Diphtheria Toxoid, Tetanus Toxoid, Algeldrate used for?

Imovax D.T. Adult is indicated for active immunization against bacterial toxin‑mediated diseases.

- Diphtheria: prevents diphtheria infection by inducing protective antibodies. - Tetanus: prevents tetanus (lockjaw) by inducing protective antibodies. - Booster immunization: maintains immunity in individuals previously vaccinated against diphtheria and tetanus.

What are the side effects of Diphtheria Toxoid, Tetanus Toxoid, Algeldrate?

Common Side Effects: - Injection site pain: mild to moderate discomfort at the injection site. - Redness or swelling: localized erythema or edema. - Low‑grade fever: transient increase in body temperature. - Headache: mild headache occurring within 24 hours. - Fatigue or malaise: general feeling of tiredness. - Mild muscle aches: transient myalgia.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Guillain‑Barré syndrome: rare neurologic disorder with muscle weakness. - High fever: temperature >39 °C persisting beyond 48 hours. - Seizures: uncommon neurologic event. - Prolonged swelling: extensive edema at the injection site. - Neurologic symptoms: such as numbness or tingling.

What precautions apply to Diphtheria Toxoid, Tetanus Toxoid, Algeldrate?

Before administration, consider the following precautions: - Hypersensitivity: avoid if known allergy to any vaccine component. - Pregnancy: use only if benefits outweigh potential risks; data are limited. - Breastfeeding: exercise caution; limited safety information is available. - Immunocompromised patients: may exhibit reduced immune response. - Concomitant vaccines: follow recommended intervals when co‑administering other vaccines. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Diphtheria Toxoid, Tetanus Toxoid, Algeldrate interact with?

Imovax D.T. Adult may interact with other agents as follows:

Major Interactions (Avoid): - Immunoglobulin or blood products within 4 weeks: may neutralize vaccine antigens. - Live bacterial vaccines given concurrently: may interfere with immune response.

Moderate Interactions (Monitor Closely): - Prophylactic antipyretics (acetaminophen, ibuprofen): may blunt antibody production. - Corticosteroids or other immunosuppressants: can reduce vaccine efficacy. - Hormonal contraceptives: no known interaction but monitor for atypical reactions.

Frequently asked questions

What is Imovax D.T. Adult used for?+
Imovax D.T. Adult is a diphtheria‑tetanus toxoid vaccine indicated for active immunization of adults and adolescents against diphtheria and tetanus. It is administered to establish or boost protective antibody levels, reducing the risk of these serious bacterial toxin‑mediated diseases.
How does the diphtheria and tetanus toxoid work?+
The vaccine contains chemically inactivated diphtheria and tetanus toxins (toxoids). When injected, the toxoids are processed by antigen‑presenting cells, which activate T‑helper cells and stimulate B‑cells to produce specific IgG antibodies. These antibodies neutralize the natural toxins, and memory cells provide long‑term protection.
What is the usual dose of Imovax D.T. Adult?+
The dosing schedule is determined by the prescribing healthcare professional. Typically, a single intramuscular dose is given, followed by booster doses at intervals recommended by national immunization guidelines or the treating physician.
Is Imovax D.T. Adult safe during pregnancy or breastfeeding?+
Safety data for use in pregnancy and lactation are limited. The vaccine should only be administered when the potential benefits to the mother outweigh any possible risks to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.
How do I order Imovax D.T. Adult from GNH USA?+
To place an order, submit an enquiry on the Imovax D.T. Adult product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details, and necessary import documentation.
How does Imovax D.T. Adult compare with other diphtheria‑tetanus vaccines?+
Imovax D.T. Adult contains diphtheria and tetanus toxoids similar to other licensed vaccines, but it may differ in preservative composition (e.g., algeldrate) and specific manufacturing processes. Clinical efficacy and safety profiles are comparable, while formulation differences can affect storage requirements and handling.
What are the storage and handling requirements for Imovax D.T. Adult?+
The vaccine must be stored refrigerated at 2 °C to 8 °C. It should be kept in the original packaging, protected from light, and must never be frozen or shaken. Proper cold‑chain management is essential to maintain potency until administration.
How is Imovax D.T. Adult administered?+
Imovax D.T. Adult is given by a single intramuscular injection, usually into the deltoid muscle, or subcutaneously if intramuscular administration is not feasible. The injection should be performed by a qualified healthcare professional using aseptic technique.
What are the most serious risks associated with Imovax D.T. Adult?+
The most serious adverse events include severe allergic reactions such as anaphylaxis and, rarely, neurologic conditions like Guillain‑Barré syndrome. Immediate medical attention is required if symptoms such as difficulty breathing, swelling of the face or throat, or rapid onset of weakness occur after vaccination.
Who should not receive Imovax D.T. Adult?+
Individuals with a known hypersensitivity to any component of the vaccine, including diphtheria or tetanus toxoids or the preservative algeldrate, should not receive it. Persons with severe immunodeficiency or those who have experienced a serious reaction to a previous dose should also avoid this vaccine.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Diphtheria Toxoid, Tetanus Toxoid, Algeldrate
Route
Intramuscular Use , Subcutaneous Use
Manufacturer
Sanofi Winthrop Industrie
Origin
EU

Related products